サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1217471

止瀉薬の世界市場レポート2023年

Antidiarrhoeals Global Market Report 2023
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.53円
止瀉薬の世界市場レポート2023年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

世界の止瀉薬市場は、2022年の38億1000万米ドルから2023年には年平均成長率（CAGR）3.5％で39億4000万米ドルに成長すると予想されます。ロシア・ウクライナ戦争は、少なくとも短期的にはCOVID-19の大流行からの世界経済回復の可能性を混乱させました。この2国間の戦争は、複数の国に対する経済制裁、商品価格の高騰、サプライチェーンの混乱につながり、商品やサービス全体にインフレを引き起こし、世界中の多くの市場に影響を与えています。止瀉薬市場は、2027年にはCAGR2.3%で43億1000万米ドルに成長すると予測されます。

止瀉薬市場レポートの対象地域は、アジア太平洋地域、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 止瀉薬市場の特徴

第3章 止瀉薬の市場動向と戦略

第4章 止瀉薬市場- マクロ経済シナリオ

第5章 止瀉薬の市場規模と成長

  • 世界の止瀉薬市場の実績、2017-2022
    • 市場の促進要因
    • 市場の抑制要因
  • 世界の止瀉薬市場の予測、2022-2027F、2032F
    • 市場の促進要因
    • 市場の抑制要因

第6章 止瀉薬市場セグメンテーション

  • 世界の止瀉薬市場、薬剤クラス別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 粘膜保護剤
  • 運動性改善薬
  • 世界の止瀉薬市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 大人
  • 子供たち
  • 世界の止瀉薬市場、タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 一般用医薬品
  • 処方薬

第7章 止瀉薬市場の地域および国の分析

  • 世界の止瀉薬市場、地域別、実績と予測、2017-2022、2022-2027F、2032F
  • 世界の止瀉薬市場、国別、実績と予測、2017-2022、2022-2027F、2032F

第8章 アジア太平洋の止瀉薬市場

  • アジア太平洋の止瀉薬市場概要
  • 地域情報, COVID-19の影響,市場情報,背景情報,政府のイニシアチブ,規制,規制機関,主要団体,課税される税,法人税構造,投資,主要企業
  • アジア太平洋の止瀉薬市場、薬剤クラス別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • アジア太平洋の止瀉薬市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第9章 中国の止瀉薬市場

  • 中国の止瀉薬市場概要
  • 中国の止瀉薬市場、薬物クラス別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 中国の止瀉薬市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第10章 インドの止瀉薬市場

  • インドの止瀉薬市場、薬剤クラス別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • インドの止瀉薬市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第11章 日本の止瀉薬市場

  • 日本の止瀉薬市場、薬剤クラス別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 日本の止瀉薬市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第12章 オーストラリアの止瀉薬市場

  • オーストラリアの止瀉薬市場、薬剤クラス別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • オーストラリアの止瀉薬市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第13章 インドネシアの止瀉薬市場

  • インドネシアの止瀉薬市場、薬剤クラス別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • インドネシアの止瀉薬市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第14章 韓国の止瀉薬市場

  • 韓国の止瀉薬市場、薬剤クラス別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 韓国の止瀉薬市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第15章 西欧の止瀉薬市場

  • 西欧の止瀉薬市場概要
  • 西欧の止瀉薬市場、薬剤クラス別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 西欧の止瀉薬市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第16章 英国の止瀉薬市場

  • 英国の止瀉薬市場、薬剤クラス別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 英国の止瀉薬市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第17章 ドイツの止瀉薬市場

  • ドイツの止瀉薬市場、薬剤クラス別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • ドイツの止瀉薬市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第18章 フランス止瀉薬市場

  • フランス止瀉薬市場、薬剤クラス別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • フランスの止瀉薬市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第19章 東欧の止瀉薬市場

  • 東欧の止瀉薬市場概要
  • 東欧の止瀉薬市場、薬物クラス別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 東欧止瀉薬市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第20章 ロシアの止瀉薬市場

  • ロシアの止瀉薬市場、薬剤クラス別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • ロシアの止瀉薬市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第21章 北米止瀉薬市場

  • 北米止瀉薬市場概要
  • 北米の止瀉薬市場、薬剤クラス別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 北米止瀉薬市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第22章 米国止瀉薬市場

  • 米国止瀉薬市場概要
  • 米国止瀉薬市場、薬剤クラス別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 米国止瀉薬市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第23章 南米止瀉薬市場

  • 南米の止瀉薬市場概要
  • 南米の止瀉薬市場、薬物クラス別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 南米の止瀉薬市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第24章 ブラジルの止瀉薬市場

  • ブラジルの止瀉薬市場、薬剤クラス別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • ブラジルの止瀉薬市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第25章 中東の止瀉薬市場

  • 中東の止瀉薬市場概要
  • 中東の止瀉薬市場、薬剤クラス別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 中東止瀉薬市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第26章 アフリカ止瀉薬市場

  • アフリカ止瀉薬市場概要
  • アフリカ止瀉薬市場、薬剤クラス別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • アフリカの止瀉薬市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第27章 止瀉薬市場の競合情勢と企業プロファイル

  • 止瀉薬市場の競合情勢
  • 止瀉薬市場の企業プロファイル
    • GlaxoSmithKline
    • Actelion
    • Perrigo
    • Lupin
    • Glenmark Pharmaceuticals

第28章 止瀉薬のパイプライン分析

第29章 止瀉薬市場における主要な合併と買収

第30章 止瀉薬市場の将来の見通しと潜在的な分析

第31章 付録

目次
Product Code: r2579

“Antidiarrhoeals Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on antidiarrhoeals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for antidiarrhoeals ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The antidiarrhoeals market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Drug Class: Mucosal Protectants; Motility Modifying Drugs

2) By Application: Adults; Childrens

3) By Type: OTC drugs; Prescription Drugs

Companies Mentioned: GlaxoSmithKline; Actelion; Perrigo; Lupin; Glenmark Pharmaceuticals

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the antidiarrhoeals market are: GlaxoSmithKline, Actelion, Perrigo, Lupin and Glenmark Pharmaceuticals, Merck & Co., Pfizer, Proctor & Gamble, Sanofi Aventis and Bayer.

The global antidiarrhoeals market will grow from $3.81 billion in 2022 to $3.94 billion in 2023 at a compound annual growth rate (CAGR) of 3.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services effecting many markets across the globe. The antidiarrhoeals market is expected to grow to $4.31 billion in 2027 at a CAGR of 2.3%.

The antidiarrheal drugs market consists of sales loperamide hydrochloride, Bismuth subsalicylate, Pepto Bismol and Imodium. Values in this market are: 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The antidiarrheal drugs refer to drugs that relieve the frequent passing of a watery, loose stool, one of the symptoms of diarrhoea. According to their shared chemical or functional properties, antidiarrheal medications can generally be grouped into three groups: adsorbents, antimotility agents, and bacterial replacements (probiotics).

The main classes of antidiarrhoeals drugs are mucosal protectants and motility modifying drugs. Mucosal protective agents are drugs that safeguard the stomach's mucosal lining from gastric acid and are employed to cure peptic ulcers. The different types include OTC drugs, and prescription drugs, which are used by adults and children.

The rise in the number of diarrhea cases significantly contributes to the growth of the antidiarrheal drug market. According to UNICEF, diarrhea was the second leading cause of death among children under the age of 5 years that is responsible for killing 760,000 children every year. An increasing number of diarrheal cases increases the demand for antidiarrheal drugs.

An increase in the use of biologics medicines poses to be a restraint to the antidiarrheal market. Biologics are medicines derived from living organisms like human beings, animals, or other microorganisms using biotechnology and are composed of proteins, sugar, nucleic acids, or a combination of each of these substances. Due to their ability to target inaccessible parts using small-molecule therapies, biologics are being preferred over traditional chemical drugs. This shift is restricting the antidiarrheal drugs market hampering its growth of the market. For example, to treat Crohn's Disease, antidiarrheal medications were being used previously, but with the advent of biologics, demand for antidiarrheal diseases has subsided.

Major companies in the antidiarrheal drug market are: merging with other companies in the market to increase their reach and market share. Companies merge with or acquire other companies to expand their market share, diversify their product portfolio, or acquire new technologies. For instance, GlaxoSmithKline agreed to acquire Novartis AG's 36.5% stake in the consumer healthcare business for $ 13 billion to expand the market.

The antidiarrheal drug industry is governed by regulatory frameworks by agencies such as US Food and Drug Administration Agency (FDA). FDA's guidelines for antidiarrheal drugs are mentioned within the CFR's (Code for Federal Regulations) title number 21 under part 335 which gives guidelines for the over-the-counter (OTC) human use of the antidiarrheal drugs. Subpart C of the regulation focuses on the labeling aspect of such drugs and mandates a statement of identity, which identifies the product is to be used for diarrhea to avoid any improper use of the drug. The FDA also regulates the warnings and directions of use of the drugs which are to be printed on the cover of these drugs.

In March 2020, Arcadia Consumer Healthcare, Inc., a USA-based pharmaceutical company acquired the Kaopectate brand from Sanofi for an undisclosed amount. This acquisition enhanced Sanofi's product portfolio by providing consumers with simple, efficacious, and high-quality solutions. Sanofi, is a France-based biopharmaceutical company focused on human health.

The regions covered in the antidiarrhoeals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the antidiarrhoeals market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from goods and/or services sold within the specified market and geography through sales, grants, or donations in terms of currency (in USD ($) unless otherwise specified).

The revenues for a specified geography are consumption values - that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced. It does not include revenues from resales either further along the supply chain or as part of other products.

The antidiarrheal drugs market research report is one of a series of new reports from The Business Research Company that provides antidiarrheal drugs market statistics, including antidiarrheal drugs industry global market size, regional shares, competitors with antidiarrheal drugs market share, detailed antidiarrheal drugs market segments, market trends and opportunities, and any further data you may need to thrive in the antidiarrheal drugs industry. This antidiarrheal drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Table of Contents

1. Executive Summary

2. Anti-diarrheal Drugs Market Characteristics

3. Anti-diarrheal Drugs Market Trends And Strategies

4. Anti-diarrheal Drugs Market - Macro Economic Scenario

4.1 COVID-19 Impact On Anti-diarrheal Drugs Market

4.2 Ukraine-Russia War Impact On Anti-diarrheal Drugs Market

4.3 Impact Of High Inflation On Anti-diarrheal Drugs Market

5. Anti-diarrheal Drugs Market Size And Growth

  • 5.1. Global Anti-diarrheal Drugs Historic Market, 2017-2022, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Anti-diarrheal Drugs Forecast Market, 2022-2027F, 2032F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Anti-diarrheal Drugs Market Segmentation

  • 6.1. Global Anti-diarrheal Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Mucosal Protectants
  • Motility Modifying Drugs
  • 6.2. Global Anti-diarrheal Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Adults
  • Childrens
  • 6.3. Global Anti-diarrheal Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • OTC drugs
  • Prescription Drugs

7. Anti-diarrheal Drugs Market Regional And Country Analysis

  • 7.1. Global Anti-diarrheal Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 7.2. Global Anti-diarrheal Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Anti-diarrheal Drugs Market

  • 8.1. Asia-Pacific Anti-diarrheal Drugs Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Anti-diarrheal Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 8.3. Asia-Pacific Anti-diarrheal Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Anti-diarrheal Drugs Market

  • 9.1. China Anti-diarrheal Drugs Market Overview
  • 9.2. China Anti-diarrheal Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
  • 9.3. China Anti-diarrheal Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Anti-diarrheal Drugs Market

  • 10.1. India Anti-diarrheal Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 10.2. India Anti-diarrheal Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Anti-diarrheal Drugs Market

  • 11.1. Japan Anti-diarrheal Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 11.2. Japan Anti-diarrheal Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Anti-diarrheal Drugs Market

  • 12.1. Australia Anti-diarrheal Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 12.2. Australia Anti-diarrheal Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Anti-diarrheal Drugs Market

  • 13.1. Indonesia Anti-diarrheal Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 13.2. Indonesia Anti-diarrheal Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Anti-diarrheal Drugs Market

  • 14.1. South Korea Anti-diarrheal Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 14.2. South Korea Anti-diarrheal Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Anti-diarrheal Drugs Market

  • 15.1. Western Europe Anti-diarrheal Drugs Market Overview
  • 15.2. Western Europe Anti-diarrheal Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 15.3. Western Europe Anti-diarrheal Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Anti-diarrheal Drugs Market

  • 16.1. UK Anti-diarrheal Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 16.2. UK Anti-diarrheal Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Anti-diarrheal Drugs Market

  • 17.1. Germany Anti-diarrheal Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 17.2. Germany Anti-diarrheal Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Anti-diarrheal Drugs Market

  • 18.1. France Anti-diarrheal Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 18.2. France Anti-diarrheal Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Anti-diarrheal Drugs Market

  • 19.1. Eastern Europe Anti-diarrheal Drugs Market Overview
  • 19.2. Eastern Europe Anti-diarrheal Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 19.3. Eastern Europe Anti-diarrheal Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Anti-diarrheal Drugs Market

  • 20.1. Russia Anti-diarrheal Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 20.2. Russia Anti-diarrheal Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Anti-diarrheal Drugs Market

  • 21.1. North America Anti-diarrheal Drugs Market Overview
  • 21.2. North America Anti-diarrheal Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 21.3. North America Anti-diarrheal Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Anti-diarrheal Drugs Market

  • 22.1. USA Anti-diarrheal Drugs Market Overview
  • 22.2. USA Anti-diarrheal Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 22.3. USA Anti-diarrheal Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Anti-diarrheal Drugs Market

  • 23.1. South America Anti-diarrheal Drugs Market Overview
  • 23.2. South America Anti-diarrheal Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 23.3. South America Anti-diarrheal Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Anti-diarrheal Drugs Market

  • 24.1. Brazil Anti-diarrheal Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 24.2. Brazil Anti-diarrheal Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Anti-diarrheal Drugs Market

  • 25.1. Middle East Anti-diarrheal Drugs Market Overview
  • 25.2. Middle East Anti-diarrheal Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 25.3. Middle East Anti-diarrheal Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Anti-diarrheal Drugs Market

  • 26.1. Africa Anti-diarrheal Drugs Market Overview
  • 26.2. Africa Anti-diarrheal Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 26.3. Africa Anti-diarrheal Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Anti-diarrheal Drugs Market Competitive Landscape And Company Profiles

  • 27.1. Anti-diarrheal Drugs Market Competitive Landscape
  • 27.2. Anti-diarrheal Drugs Market Company Profiles
    • 27.2.1. GlaxoSmithKline
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Actelion
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Perrigo
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Lupin
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Glenmark Pharmaceuticals
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Anti-diarrheal Drugs Pipeline Analysis

29. Key Mergers And Acquisitions In The Anti-diarrheal Drugs Market

30. Anti-diarrheal Drugs Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Historic And Forecast Inflation Rates
  • 31.4. Research Inquiries
  • 31.5. The Business Research Company
  • 31.6. Copyright And Disclaimer